Viewing Study NCT05906251


Ignite Creation Date: 2025-12-24 @ 11:46 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT05906251
Status: TERMINATED
Last Update Posted: 2025-09-04
First Post: 2023-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related)
Sponsor: Sarepta Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-22
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-13
Primary Completion Date Type: ACTUAL
Completion Date: 2025-06-13
Completion Date Type: ACTUAL
First Submit Date: 2023-06-07
First Submit QC Date: None
Study First Post Date: 2023-06-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-27
Last Update Post Date: 2025-09-04
Last Update Post Date Type: ESTIMATED